Clinical cancer research has yielded tremendous gains, leading to longersurvivalandbetterqualityoflifeforthem…
Americans diagnosed with the disease each year. Great strides in cancer prevention have …

Background Drug-coated balloons (DCB) are a novel therapeutic strategy for small native
coronary artery disease. However, their safety and efficacy is poorly defined in comparison …

Aims To assess the feasibility, short‐term durability and clinical outcomes of MitraClip®
therapy for mitral regurgitation (MR) in patients with end‐stage heart failure and a severely …

In 2009, ASCO and the Oncology Nursing Society (ONS) published standards for the safe
use of parenteral chemotherapy in the outpatient setting, including issues of practitioner …

Objective The study sought to provide physicians, informaticians, and institutional
policymakers with an introductory tutorial about the history of medical documentation …

Purpose The Quality Oncology Practice Initiative (QOPI) is a practice-based system of quality
self-assessment sponsored by the participants and the American Society of Clinical …

Background In the treatment of de-novo coronary small vessel disease, drug-coated
balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up …

Aims Cardiac contractility modulation (CCM) is a new form of electrical therapy in patients
with congestive heart failure. Recently published clinical studies provide evidence of safety …

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the
American Society of Clinical Oncology - PMC Back to Top Skip to main content NIH NLM Logo …

Abstract Objectives: Angiotensin II (Ang II) induces fibroblast proliferation and collagen
synthesis in the myocardium, but its precise mechanisms of action in human hearts are still …